Structures by: Valigura D.
Total: 19
Pyridine-2,6-dicarboxylato-2,6-bis(hydroxymethyl)pyridine-nickel(II) monohydrate
C14H14N2NiO7
Dalton transactions (Cambridge, England : 2003) (2015) 44, 28 12484-12487
a=6.5850(10)Å b=25.608(4)Å c=8.6560(10)Å
α=90° β=96.730(10)° γ=90°
C14H18N2NiO4,2(C7H3N2O6)
C14H18N2NiO4,2(C7H3N2O6)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 31 11647-11650
a=7.9708(2)Å b=13.7985(4)Å c=14.6800(4)Å
α=96.452(2)° β=103.366(2)° γ=100.715(2)°
C14H18CoN2O4,2(C7H3N2O6)
C14H18CoN2O4,2(C7H3N2O6)
Dalton Trans. (2017)
a=7.9759(4)Å b=13.8721(7)Å c=14.7030(7)Å
α=96.108(4)° β=105.136(4)° γ=100.589(4)°
C24H28CoDyN4O14
C24H28CoDyN4O14
Dalton transactions (Cambridge, England : 2003) (2016) 45, 17 7510-7520
a=11.029(2)Å b=14.281(3)Å c=18.943(4)Å
α=90° β=96.809(7)° γ=90°
C22H24CoDyN4O14
C22H24CoDyN4O14
Dalton transactions (Cambridge, England : 2003) (2016) 45, 17 7510-7520
a=10.7189(9)Å b=15.8478(14)Å c=16.4828(15)Å
α=90° β=98.315(3)° γ=90°
Poly[[bis(4-chlorosalicylato-κ<i>O</i>)copper(II)]-di-μ-3-pyridylmethanol- κ^2^N:O;κ^2^O:N]
C26H22Cl2CuN2O8
Acta Crystallographica Section E (2006) 62, 5 m1164-m1166
a=11.031(2)Å b=12.815(3)Å c=9.3410(2)Å
α=90.00° β=104.16(3)° γ=90.00°
1H-nicotinamidium 3,5-dinitrosalicylate
C6H7N2O11,C7H3N2O71
Acta Crystallographica Section E (2003) 59, 4 o441-o442
a=4.7400(10)Å b=21.968(4)Å c=13.858(3)Å
α=90.00° β=94.62(3)° γ=90.00°
Bis(3-nitrobenzoato)bis(3-pyridylmethanol-N,O)copper(II) complex
C26H22CuN4O10
Acta Crystallographica Section E (2005) 61, 5 m994-m996
a=6.6920(13)Å b=7.6470(15)Å c=12.997(3)Å
α=83.72(3)° β=77.11(3)° γ=80.69(3)°
Trans-diaquabis(N,N-diethylnicotinamide-κN)bis(3-methoxysalicylato- κO)copper(II) dihydrate
C36H46CuN4O12,2H2O
Acta Crystallographica Section E (2006) 62, 3 m448-m450
a=8.544(2)Å b=12.558(3)Å c=18.617(5)Å
α=90.00° β=96.63(3)° γ=90.00°
(3,5-Dinitrobenzoato-κ^2^O,O)bis[(2-pyridyl)methanol-κ^2^N,O]copper(II) 3,5-dinitrobenzoate
C19H17CuN4O8,C7H3N2O6
Acta Crystallographica Section E (2006) 62, 1 m109-m110
a=9.8700(10)Å b=12.1810(10)Å c=12.7320(10)Å
α=95.290(10)° β=108.680(10)° γ=91.800(10)°
C11H12Cl2CuN2O3
C11H12Cl2CuN2O3
Acta Crystallographica Section C (1991) 47, 12 2529-2531
a=16.420(5)Å b=8.545(2)Å c=19.001(4)Å
α=90° β=90.300(10)° γ=90°
C24H16Cl2Cu1N4O2,2(H2O1)
C24H16Cl2Cu1N4O2,2(H2O1)
Acta Crystallographica Section C (1992) 48, 1 31-33
a=8.586(6)Å b=8.790(8)Å c=8.770(6)Å
α=68.23(6)° β=62.42(5)° γ=86.08(7)°
C94H102Cu4O14P4
C94H102Cu4O14P4
Acta Crystallographica Section C (1995) 51, 6 1082-1084
a=13.537(10)Å b=14.111(7)Å c=12.060(10)Å
α=99.98(6)° β=90.24(7)° γ=94.02(6)°
Dichloro-tetrakis{(2-pyridyl)pyrazine}copper(II) complex, C~24~H~16~N~6~Cl~2~Cu
C24H16Cl2CuN6
Acta Crystallographica Section C (1997) 53, 12 1813-1815
a=14.5643(11)Å b=7.1338(11)Å c=21.231(2)Å
α=90.00° β=105.021(8)° γ=90.00°
C32H32N6Ni2O10,C1H2O1
C32H32N6Ni2O10,C1H2O1
Acta Crystallographica Section C (1998) 54, 9 1277-1279
a=12.681(3)Å b=12.145(2)Å c=22.107(4)Å
α=90.00° β=90.35(3)° γ=90.00°
Tetrakis(μ-2-nitrobenzoato-κ^2^<i>O</i>:<i>O</i>)bis[aquacopper(II)] ethanol solvate
C28H20Cu2N4O18,2(C2H6O)
Acta Crystallographica Section E (2006) 62, 12 m3217-m3219
a=8.326(3)Å b=20.028(6)Å c=10.803(3)Å
α=90.00° β=97.77(3)° γ=90.00°
Tetrakis(μ-3,5-dinitrobenzoato-κ^2^O:O)bis[(caffeine-κO)copper(II)]
C44H32Cu2N16O28
Acta Crystallographica Section C (2006) 62, 8 m375-m377
a=12.900(5)Å b=12.900(5)Å c=30.330(3)Å
α=90.00° β=90.00° γ=90.00°
2-(1,3-Benzimidazol-2-io)-6-(1,3-benzimidazol-2-yl)pyridine perchlorate monohydrate
C19H14N5,ClO4,H2O
Acta Crystallographica Section C (2000) 56, 7 838-839
a=9.168(2)Å b=15.111(3)Å c=13.962(3)Å
α=90.00° β=101.98(2)° γ=90.00°
C14H12CuN2O6,0.5(H2O)
C14H12CuN2O6,0.5(H2O)
Inorganic chemistry (2017) 56, 3 1478-1482
a=8.6646(3)Å b=22.9611(7)Å c=14.5027(5)Å
α=90° β=102.904(3)° γ=90°